Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aptus Pharma Ltd has submitted a quarterly compliance certificate to BSE as required under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate, issued by its Registrar and Share Transfer Agent — Accurate Securities & Registry Private Limited — covers the quarter ended 31st December 2025. It confirms that securities received from the depository have been properly processed and reconciled. The letter was signed by Managing Director Tejash Hathi on 10 January 2026. This is a routine procedural filing and does not contain any business or financial updates.
No impact on shareholders or the stock price. This is a standard regulatory compliance submission confirming that share transfer and demat activities for the quarter were handled correctly.